Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Exploitation of lectinized lipo-polymerosome encapsulated Amphotericin B to target macrophages for effective chemotherapy of visceral leishmaniasis.

Gupta PK, Asthana S, Jaiswal AK, Kumar V, Verma AK, Shukla P, Dwivedi P, Dube A, Mishra PR.

Bioconjug Chem. 2014 Jun 18;25(6):1091-102. doi: 10.1021/bc500087h. Epub 2014 Jun 9.

PMID:
24842628
[PubMed - in process]
2.

Covalent functionalized self-assembled lipo-polymerosome bearing amphotericin B for better management of leishmaniasis and its toxicity evaluation.

Gupta PK, Jaiswal AK, Kumar V, Verma A, Dwivedi P, Dube A, Mishra PR.

Mol Pharm. 2014 Mar 3;11(3):951-63. doi: 10.1021/mp400603t. Epub 2014 Feb 19.

PMID:
24495144
[PubMed - in process]
3.

Immunoadjuvant chemotherapy of visceral leishmaniasis in hamsters using amphotericin B-encapsulated nanoemulsion template-based chitosan nanocapsules.

Asthana S, Jaiswal AK, Gupta PK, Pawar VK, Dube A, Chourasia MK.

Antimicrob Agents Chemother. 2013 Apr;57(4):1714-22. doi: 10.1128/AAC.01984-12. Epub 2013 Jan 28.

PMID:
23357762
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Development of targeted 1,2-diacyl-sn-glycero-3-phospho-l-serine-coated gelatin nanoparticles loaded with amphotericin B for improved in vitro and in vivo effect in leishmaniasis.

Khatik R, Dwivedi P, Khare P, Kansal S, Dube A, Mishra PR, Dwivedi AK.

Expert Opin Drug Deliv. 2014 May;11(5):633-46. doi: 10.1517/17425247.2014.889678. Epub 2014 Mar 7.

PMID:
24606222
[PubMed - indexed for MEDLINE]
5.

Lipid formulations of amphotericin b in the treatment of experimental visceral leishmaniasis due to Leishmania infantum.

Gangneux JP, Sulahian A, Garin YJ, Derouin F.

Trans R Soc Trop Med Hyg. 1996 Sep-Oct;90(5):574-7.

PMID:
8944278
[PubMed - indexed for MEDLINE]
6.

Chitosan-assisted immunotherapy for intervention of experimental leishmaniasis via amphotericin B-loaded solid lipid nanoparticles.

Jain V, Gupta A, Pawar VK, Asthana S, Jaiswal AK, Dube A, Chourasia MK.

Appl Biochem Biotechnol. 2014 Oct;174(4):1309-30. doi: 10.1007/s12010-014-1084-y. Epub 2014 Aug 9.

PMID:
25106894
[PubMed - in process]
7.

Therapy of visceral leishmaniasis due to Leishmania infantum: experimental assessment of efficacy of AmBisome.

Gangneux JP, Sulahian A, Garin YJ, Farinotti R, Derouin F.

Antimicrob Agents Chemother. 1996 May;40(5):1214-8.

PMID:
8723469
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Development and characterization of amphotericin B bearing emulsomes for passive and active macrophage targeting.

Gupta S, Vyas SP.

J Drug Target. 2007 Apr;15(3):206-17.

PMID:
17454358
[PubMed - indexed for MEDLINE]
9.

Comparison of LNS-AmB, a novel low-dose formulation of amphotericin B with lipid nano-sphere (LNS), with commercial lipid-based formulations.

Fukui H, Koike T, Nakagawa T, Saheki A, Sonoke S, Tomii Y, Seki J.

Int J Pharm. 2003 Nov 28;267(1-2):101-12.

PMID:
14602388
[PubMed - indexed for MEDLINE]
10.

Antileishmanial activity of liposome-encapsulated amphotericin B in hamsters and monkeys.

Berman JD, Hanson WL, Chapman WL, Alving CR, Lopez-Berestein G.

Antimicrob Agents Chemother. 1986 Dec;30(6):847-51.

PMID:
3813512
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Antileishmanial activity, uptake, and biodistribution of an amphotericin B and poly(α-Glutamic Acid) complex.

Mohamed-Ahmed AH, Seifert K, Yardley V, Burrell-Saward H, Brocchini S, Croft SL.

Antimicrob Agents Chemother. 2013 Oct;57(10):4608-14. doi: 10.1128/AAC.02343-12. Epub 2013 Jun 24.

PMID:
23796924
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Comparison of the efficacies of various formulations of amphotericin B against murine visceral leishmaniasis.

Mullen AB, Carter KC, Baillie AJ.

Antimicrob Agents Chemother. 1997 Oct;41(10):2089-92.

PMID:
9333030
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Antileishmanial efficacy of amphotericin B bearing emulsomes against experimental visceral leishmaniasis.

Gupta S, Dube A, Vyas SP.

J Drug Target. 2007 Jul;15(6):437-44.

PMID:
17613662
[PubMed - indexed for MEDLINE]
14.

Amphotericin B formulations: a comparative review of efficacy and toxicity.

Hamill RJ.

Drugs. 2013 Jun;73(9):919-34. doi: 10.1007/s40265-013-0069-4. Review.

PMID:
23729001
[PubMed - indexed for MEDLINE]
15.

Treatment of experimental visceral leishmaniasis with amphotericin B in stable albumin microspheres.

Sánchez-Brunete JA, Dea MA, Rama S, Bolás F, Alunda JM, Raposo R, Méndez MT, Torrado-Santiago S, Torrado JJ.

Antimicrob Agents Chemother. 2004 Sep;48(9):3246-52.

PMID:
15328080
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Efficacious treatment of experimental leishmaniasis with amphotericin B-arabinogalactan water-soluble derivatives.

Golenser J, Frankenburg S, Ehrenfreund T, Domb AJ.

Antimicrob Agents Chemother. 1999 Sep;43(9):2209-14.

PMID:
10471566
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

A comparison of the activities of three amphotericin B lipid formulations against experimental visceral and cutaneous leishmaniasis.

Yardley V, Croft SL.

Int J Antimicrob Agents. 2000 Feb;13(4):243-8.

PMID:
10755238
[PubMed - indexed for MEDLINE]
18.

Visceral leishmaniasis affects liver and spleen concentrations of amphotericin B following administration to mice.

Gershkovich P, Wasan EK, Sivak O, Li R, Zhu X, Werbovetz KA, Tidwell RR, Clement JG, Thornton SJ, Wasan KM.

J Antimicrob Chemother. 2010 Mar;65(3):535-7. doi: 10.1093/jac/dkp465. Epub 2009 Dec 21.

PMID:
20026611
[PubMed - indexed for MEDLINE]
Free Article
19.

Efficacy of low doses of amphotericin B plus allicin against experimental visceral leishmaniasis.

Corral MJ, Serrano DR, Moreno I, Torrado JJ, Domínguez M, Alunda JM.

J Antimicrob Chemother. 2014 Dec;69(12):3268-74. doi: 10.1093/jac/dku290. Epub 2014 Aug 4.

PMID:
25096077
[PubMed - in process]
20.

Biodistribution of liposomal amphotericin B (AmBisome) and amphotericin B-desoxycholate (Fungizone) in uninfected immunocompetent mice and leucopenic mice infected with Candida albicans.

van Etten EW, Otte-Lambillion M, van Vianen W, ten Kate MT, Bakker-Woudenberg AJ.

J Antimicrob Chemother. 1995 Apr;35(4):509-19.

PMID:
7628985
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk